There was also a 36% reduction in the fasting blood glucose level (p < 0.0001), a >95% reduction in the fasting serum insulin (p < 0.05), and a >95% reduction in the homeostatic model assessment for insulin resistance (HOMA-IR, p < 0.05) compared to the pair-fed vehicle control. The gene discussed is INS; the disease is Insulin resistance.